Pharmaceutical Science

A topic in the Science corpus, drawn from 673 papers.

Trusted voices in Pharmaceutical Science

Ordered by the trust Pharmaceutical Science's own network concentrates on each researcher, most first.

  1. R. Müller — trusted by 48 researchers here
  2. Mark R. Prausnitz — trusted by 33 researchers here
  3. M. N. R. Kumar — trusted by 39 researchers here
  4. K. Mäder — trusted by 30 researchers here
  5. J. Breitenbach — trusted by 25 researchers here
  6. Colin W. Pouton — trusted by 19 researchers here
  7. B. Rabinow — trusted by 20 researchers here
  8. R. Cone — trusted by 12 researchers here
  9. H. Gill — trusted by 11 researchers here
  10. J. Siepmann — trusted by 14 researchers here
  11. Matthew Zeller — trusted by 13 researchers here
  12. Gerald O. Hunter — trusted by 13 researchers here

Most-cited papers in Pharmaceutical Science

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. Molecular properties that influence the oral bioavailability of drug candidates. (2002, Journal of Medicinal Chemistry) — 7,371 citations
  2. Engineering precision nanoparticles for drug delivery (2020, Nature reviews. Drug discovery) — 6,130 citations
  3. A review of chitin and chitosan applications (2000) — 5,755 citations
  4. Modeling and comparison of dissolution profiles. (2001, European Journal of Pharmaceutical Sciences) — 5,510 citations
  5. Stimuli-responsive nanocarriers for drug delivery. (2013, Nature Materials) — 5,473 citations
  6. Fluorine in Pharmaceuticals: Looking Beyond Intuition (2007, Science) — 5,105 citations
  7. Nano based drug delivery systems: recent developments and future prospects (2018, Journal of Nanobiotechnology) — 5,098 citations
  8. trans-Dimethanolbis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato)zinc(II) (2008, Acta Crystallographica Section E) — 4,605 citations
  9. Drug Delivery Systems: Entering the Mainstream (2004, Science) — 4,318 citations
  10. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011, Polymers) — 4,247 citations
  11. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems (2018, Pharmaceutics) — 4,149 citations
  12. Designing hydrogels for controlled drug delivery (2016, Nature Reviews Materials) — 4,033 citations
  13. Fluorine in medicinal chemistry. (2008, Chemical Society Reviews) — 3,994 citations
  14. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery (2015, Advanced Drug Delivery Reviews) — 3,831 citations
  15. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011). (2014, Chemical Reviews) — 3,665 citations
  16. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. (2000, European journal of pharmaceutics and biopharmaceutics) — 3,522 citations
  17. PLGA-based nanoparticles: an overview of biomedical applications. (2012, Journal of Controlled Release) — 3,515 citations
  18. HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES (2008) — 3,515 citations
  19. Biodegradable polymeric nanoparticles based drug delivery systems. (2010, Colloids and Surfaces B: Biointerfaces) — 3,504 citations
  20. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. (2003, Advanced Drug Delivery Reviews) — 3,323 citations
  21. Biodegradable polymeric nanoparticles as drug delivery devices. (2001, Journal of Controlled Release) — 3,319 citations
  22. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. (2010, Angewandte Chemie) — 3,209 citations
  23. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). (2001, Advanced Drug Delivery Reviews) — 3,086 citations
  24. Solid lipid nanoparticles: production, characterization and applications. (2001, Advanced Drug Delivery Reviews) — 3,056 citations
  25. The many roles for fluorine in medicinal chemistry. (2008, Journal of Medicinal Chemistry) — 2,892 citations
  26. Chitosan chemistry and pharmaceutical perspectives. (2004, Chemical Reviews) — 2,817 citations
  27. Improving drug solubility for oral delivery using solid dispersions. (2000, European journal of pharmaceutics and biopharmaceutics) — 2,772 citations
  28. Liposome: classification, preparation, and applications (2013, Nanoscale Research Letters) — 2,766 citations
  29. Environment-sensitive hydrogels for drug delivery (2001) — 2,751 citations
  30. Chitosan—A versatile semi-synthetic polymer in biomedical applications (2011) — 2,689 citations
  31. Applications of Fluorine in Medicinal Chemistry. (2015, Journal of Medicinal Chemistry) — 2,644 citations
  32. Nanoparticle-based targeted drug delivery (2009, Experimental and molecular pathology (Print)) — 2,559 citations
  33. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. (2004, Journal of Controlled Release) — 2,508 citations
  34. Transdermal drug delivery (2008, Nature Biotechnology) — 2,506 citations
  35. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release (2016, Chemical Reviews) — 2,506 citations
  36. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. (2010, Biomaterials) — 2,415 citations
  37. Understanding organofluorine chemistry. An introduction to the C-F bond. (2008, Chemical Society Reviews) — 2,363 citations
  38. Chitosan-based hydrogels for controlled, localized drug delivery. (2010, Advanced Drug Delivery Reviews) — 2,321 citations
  39. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. (2000, New England Journal of Medicine) — 2,255 citations
  40. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. (2000, Biomaterials) — 2,166 citations
  41. Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes (2006, Nature Protocols) — 2,058 citations
  42. Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2) (2013) — 2,038 citations
  43. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. (2016, Chemical Reviews) — 2,014 citations
  44. Introduction of fluorine and fluorine-containing functional groups. (2013, Angewandte Chemie) — 1,972 citations
  45. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. (2006, Journal of Controlled Release) — 1,955 citations
  46. The skin: an indispensable barrier (2008, Experimental Dermatology) — 1,952 citations
  47. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. (2005, Journal of Clinical Oncology) — 1,927 citations
  48. Cyclodextrin-based pharmaceutics: past, present and future (2004, Nature reviews. Drug discovery) — 1,884 citations
  49. Dual Catalysis Strategies in Photochemical Synthesis (2016, Chemical Reviews) — 1,869 citations
  50. Cyclodextrins as pharmaceutical solubilizers. (2007, Advanced Drug Delivery Reviews) — 1,822 citations

Most active researchers

By papers in this topic: a volume measure, not trust.